Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
---|---|---|
2023-10 | A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity | Lee, Dong-hee; Ahn, Hyejin; Sim hye in; Choi, Eunji; Choi, Seung hyun; JO, YUNJU; Yun, Bohwan; Song, Hyun Kyu; Oh, Soo Jin; Denda-Nagai, Kaori; Park, Chan-Sik; Irimura, Tatsuro; Park, Yoon; Jin, Hyung-seung |
2025-07 | Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma | Kim, Seok Jin; Lim, Jing Quan; Yoon, Sang Eun; Yang, Deok-Hwan; Lee, Ji Hyun; Oh, Sung Yong; Choi, Yoon Seok; Jeong, Seong Hyun; Kim, Min Kyoung; Lim, Sung Nam; Cho, Junhun; Park, Bon; Ryu, Kyung Ju; Choi, Seung hyun; Park, Yoon; Lim, Kerry May Huifen; Taib, Nur Ayuni Binte Muhammad; Ong, Choon Kiat; Lim, Soon Thye; Kim, Won Seog |
2022-08 | LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation | Eunsil Sung; KO MIN KYUNG; Ju-youngWon; JO, YUNJU; EunyoungPark; HyunjooKim; Eunji Choi; Ui-jung Jung; Jaehyoung Jeon; Youngkwang Kim; Hyejin Ahn; Da-som Choi; Choi, Seung hyun; Youngeun Hong; Hyeyoung Park; Hanbyul Lee; Yong-Gyu Son; Kyeongsu Park; Jonghwa Won; Soo Jin Oh; Seonmin Lee; Kyu-pyo Kim; Changhoon Yoo; Hyun Kyu Song; Hyung-seung Jin; Jaeho Jung; Park, Yoon |
2023-05 | The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma | Sang Eun Yoon; Woorim Kang; Choi, Seung hyun; Park, Yoon; Mauricio Chalita; Hyun Kim; Je Hee Lee; Dong-Wook Hyun; Kyung Ju Ryu; Hojun Sung; Jae-Yun Lee; Jin-Woo Bae; Won seog Kim; Seok-Jin Kim |